Ticker
NPCECompany Name
NEUROPACE INCSector
HealthcareIndustry
Medical DevicesExchange
NASDAQDate | Cash Return on Invested Capital | Free Cash Flow | Invested Capital |
---|---|---|---|
6/30/2025 | -18.07% | $ -16.43M | $ 90.96M |
3/31/2025 | -18.62% | $ -18.14M | $ 97.42M |
12/31/2024 | -22.44% | $ -18.25M | $ 81.35M |
9/30/2024 | -20.15% | $ -16.79M | $ 83.32M |
6/30/2024 | -20.68% | $ -17.28M | $ 83.55M |
3/31/2024 | -20.22% | $ -17.68M | $ 87.43M |
12/31/2023 | -21.36% | $ -19.87M | $ 93.05M |
9/30/2023 | -27.76% | $ -24.45M | $ 88.06M |
6/30/2023 | -31.59% | $ -29.14M | $ 92.24M |
3/31/2023 | -36.38% | $ -35.6M | $ 97.86M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Inv. Capital
(=) CROIC
CROIC for NEUROPACE INC is calculated as follows: FCF [ $ -21.67M ] / Inv. Capital [ $ -94.97M ]
(=) CROIC [ 0% ]
Minimum
Mar 31, 2023
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.46K |
---|---|
min | -43.78% |
max | 49.3% |
average | 2.78% |
median | 4.97% |
std | 15.04% |